{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:23:19Z","timestamp":1788909799227,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Roux-en-Y Gastric Bypass Surgery (RYGB) prevents the occurrence of pancreatic cell acinar carcinoma (ACC) in male and female <jats:italic>Ngn3-Tsc1<\/jats:italic>\u2212\/\u2212 mice. <jats:italic>Ngn3<\/jats:italic> directed <jats:italic>Cre<\/jats:italic> deletion of <jats:italic>Tsc1<\/jats:italic> gene induced the development of pancreatic ACC. The transgenic mice with sham surgery demonstrated a cancer incidence of 96.7\u2009\u00b1\u20093.35% and survival rate of 67.0\u2009\u00b1\u20091.4% at the age of 300 days. Metastasis to liver and kidney was observed in 69.7\u2009\u00b1\u20099.7% and 44.3\u2009\u00b1\u20098.01% of these animals, respectively. All animals with RYGB performed at the age of 16 weeks survived free of pancreatic ACC up to the age of 300 days. RYGB significantly attenuated the activation of mTORC1 signaling and inhibition of tumor suppressor genes: p21, p27, and p53 in pancreatic ACC. Our studies demonstrate that bariatric surgery may limit the occurrence and growth of pancreatic ACC through the suppression of mTORC1 signaling in pancreas. RYGB shows promise for intervention of both metabolic dysfunction and organ cancer.<\/jats:p>","DOI":"10.1038\/s41467-018-06571-w","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:57:52Z","timestamp":1538650672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery"],"prefix":"10.1038","volume":"9","author":[{"given":"Rui","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"6571_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74\u2013108 (2005).","journal-title":"CA Cancer J. Clin."},{"key":"6571_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal, A. et al. Cancer statistics, 2004. CA Cancer J. Clin. 54, 8\u201329 (2004).","journal-title":"CA Cancer J. Clin."},{"key":"6571_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2012.03.002","volume":"142","author":"PA Perez-Mancera","year":"2012","unstructured":"Perez-Mancera, P. A., Guerra, C., Barbacid, M. & Tuveson, D. A. What we have learned about pancreatic cancer from mouse models. Gastroenterology 142, 1079\u20131092 (2012).","journal-title":"Gastroenterology"},{"key":"6571_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"6571_CR5","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1716173114","volume":"114","author":"DM Sabatini","year":"2017","unstructured":"Sabatini, D. M. Twenty-five years of mTOR: Uncovering the link from nutrients to growth. Proc. Natl Acad. Sci. USA 114, 11818\u201311825 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6571_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/cr.2007.64","volume":"17","author":"Q Yang","year":"2007","unstructured":"Yang, Q. & Guan, K. L. Expanding mTOR signaling. Cell Res 17, 666\u2013681 (2007).","journal-title":"Cell Res"},{"key":"6571_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.neo.2014.08.010","volume":"16","author":"L Ding","year":"2014","unstructured":"Ding, L. et al. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma. Neoplasia 16, 909\u2013917 (2014).","journal-title":"Neoplasia"},{"key":"6571_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep03230","volume":"3","author":"S Matsubara","year":"2013","unstructured":"Matsubara, S. et al. mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions. Sci. Rep. 3, 3230 (2013).","journal-title":"Sci. Rep."},{"key":"6571_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao, Y. et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199\u20131203 (2011).","journal-title":"Science"},{"key":"6571_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJM199202133260706","volume":"326","author":"AL Warshaw","year":"1992","unstructured":"Warshaw, A. L. & Fernandez-del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med 326, 455\u2013465 (1992).","journal-title":"N. Engl. J. Med"},{"key":"6571_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pan.2013.11.001","volume":"14","author":"P Jin","year":"2014","unstructured":"Jin, P., Ji, X., Ren, H., Tang, Y. & Hao, J. Resection or cryosurgery relates with pancreatic tumor type: primary pancreatic cancer with previous non-pancreatic cancer or secondary metastatic cancer within the pancreas. Pancreatology 14, 64\u201370 (2014).","journal-title":"Pancreatology"},{"key":"6571_CR12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.soard.2016.05.010","volume":"12","author":"T Debs","year":"2016","unstructured":"Debs, T. et al. Trends of bariatric surgery in France during the last 10 years: analysis of 267,466 procedures from 2005-2014. Surg. Obes. Relat. Dis. 12, 1602\u20131609 (2016).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"6571_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ebiom.2018.01.032","volume":"28","author":"R He","year":"2018","unstructured":"He, R. et al. Esophagus-duodenum gastric bypass surgery improves glucose and lipid metabolism in mice. EBioMedicine 28, 241\u2013250 (2018).","journal-title":"EBioMedicine"},{"key":"6571_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","volume":"10","author":"L Sjostrom","year":"2009","unstructured":"Sjostrom, L. et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 10, 653\u2013662 (2009).","journal-title":"Lancet Oncol."},{"key":"6571_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri, P., Frasca, F., Sciacca, L., Pandini, G. & Vigneri, R. Diabetes and cancer. Endocr. Relat. Cancer 16, 1103\u20131123 (2009).","journal-title":"Endocr. Relat. Cancer"},{"key":"6571_CR16","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/cncr.25738","volume":"117","author":"H Ashrafian","year":"2011","unstructured":"Ashrafian, H. et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer 117, 1788\u20131799 (2011).","journal-title":"Cancer"},{"key":"6571_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1470-2045(09)70170-6","volume":"10","author":"AG Renehan","year":"2009","unstructured":"Renehan, A. G. Bariatric surgery, weight reduction, and cancer prevention. Lancet Oncol. 10, 640\u2013641 (2009).","journal-title":"Lancet Oncol."},{"key":"6571_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625\u20131638 (2003).","journal-title":"N. Engl. J. Med."},{"key":"6571_CR19","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s11695-016-2206-0","volume":"26","author":"MA Hunsinger","year":"2016","unstructured":"Hunsinger, M. A. et al. Maximizing weight loss after Roux-en-Y Gastric Bypass may decrease risk of incident organ cancer. Obes. Surg. 26, 2856\u20132861 (2016).","journal-title":"Obes. Surg."},{"key":"6571_CR20","doi-asserted-by":"publisher","first-page":"F9","DOI":"10.1530\/ERC-12-0105","volume":"19","author":"Y Cui","year":"2012","unstructured":"Cui, Y. & Andersen, D. K. Diabetes and pancreatic cancer. Endocr. Relat. Cancer 19, F9\u2013F26 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"6571_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2337\/dc14-1996","volume":"38","author":"JL Harding","year":"2015","unstructured":"Harding, J. L., Shaw, J. E., Peeters, A., Cartensen, B. & Magliano, D. J. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 38, 734\u2013735 (2015).","journal-title":"Diabetes Care"},{"key":"6571_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/MPA.0000000000000833","volume":"46","author":"S Mizuno","year":"2017","unstructured":"Mizuno, S. et al. Prevalence of pancreatic cystic lesions is associated with diabetes mellitus and obesity: An analysis of 5296 individuals who underwent a preventive medical examination. Pancreas 46, 801\u2013805 (2017).","journal-title":"Pancreas"},{"issue":"Suppl 2","key":"6571_CR23","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1038\/onc.2009.352","volume":"27","author":"S Menon","year":"2008","unstructured":"Menon, S. & Manning, B. D. Common corruption of the mTOR signaling network in human tumors. Oncogene 27(Suppl 2), S43\u2013S51 (2008).","journal-title":"Oncogene"},{"key":"6571_CR24","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1074\/jbc.M112.399485","volume":"288","author":"AK Murugan","year":"2013","unstructured":"Murugan, A. K., Alzahrani, A. & Xing, M. Mutations in critical domains confer the human mTOR gene strong tumorigenicity. J. Biol. Chem. 288, 6511\u20136521 (2013).","journal-title":"J. Biol. Chem."},{"key":"6571_CR25","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1158\/0008-5472.CAN-12-2014","volume":"73","author":"A Khalaileh","year":"2013","unstructured":"Khalaileh, A. et al. Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. Cancer Res 73, 1811\u20131820 (2013).","journal-title":"Cancer Res"},{"key":"6571_CR26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"6571_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/MPA.0000000000000844","volume":"46","author":"GA Talmon","year":"2017","unstructured":"Talmon, G. A., Wren, J. D., Nguyen, C. L. & Pour, P. M. Pancreatic polypeptide cell proliferation in the pancreas and duodenum coexisting in a patient with pancreatic adenocarcinoma treated with a GLP-1 analog. Pancreas 46, 820\u2013824 (2017).","journal-title":"Pancreas"},{"key":"6571_CR28","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1210\/en.2017-00564","volume":"158","author":"CR Hutch","year":"2017","unstructured":"Hutch, C. R. & Sandoval, D. The role of GLP-1 in the metabolic success of bariatric surgery. Endocrinology 158, 4139\u20134151 (2017).","journal-title":"Endocrinology"},{"key":"6571_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ebiom.2018.05.026","volume":"32","author":"H Zhai","year":"2018","unstructured":"Zhai, H. et al. Takeda G protein-coupled receptor 5-mechanistic target of rapamycin complex 1 signaling contributes to the increment of glucagon-like peptide-1 production after Roux-en-Y Gastric Bypass. EBioMedicine 32, 201\u2013214 (2018).","journal-title":"EBioMedicine"},{"key":"6571_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/db13-0954","volume":"63","author":"M Shah","year":"2014","unstructured":"Shah, M. et al. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes 63, 483\u2013493 (2014).","journal-title":"Diabetes"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06571-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06571-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06571-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T18:50:44Z","timestamp":1671562244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06571-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6571"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06571-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"assertion":[{"value":"3 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4183"}}